Last reviewed · How we verify
NCT06576999
Sensor-based Balance Training With Exergaming Biofeedback
NA trial testing Sensor-based Balance Training in Stroke, Ischemic in 21 participants. Completed in 31 July 2024.
27 July 2024
Quick facts
| Lead sponsor | I.R.C.C.S. Fondazione Santa Lucia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 1 May 2017 |
| Primary completion | 27 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Sensor-based Balance Training
- Usual Balance Trainging
Conditions studied
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
Sponsor
I.R.C.C.S. Fondazione Santa Lucia — full company profile →
Who can join
Adults 18 to 80, any sex, with Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the effects of a sensor-based balance training with exergaming feedback on balance skills in chronic stroke patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sensor-Based Balance Training with Exergaming Feedback in Subjects with Chronic Stroke: A Pilot Randomized Controlled Trial.
Martino Cinnera A, Ciancarelli I, Marrano S, Palagiano M, et al · · 2024 · cited 1× · PMID 39335412 · DOI 10.3390/brainsci14090917
Verify or expand the search:
- PubMed search for NCT06576999
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Ischemic
Currently open trials in the same condition.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
- NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
- NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting
Other I.R.C.C.S. Fondazione Santa Lucia trials
Trials by the same sponsor.
- NCT07257679 — Gentle Touch for Post-Mastectomy Lymphedema · Phase 4 · recruiting
- NCT07254377 — Design and Validation of Innovative Strategies Based on Dual-Task Approach · NA · active not recruiting
- NCT06420271 — Effects of Cerebellar tACS-iTBS in Ataxia · NA · recruiting
- NCT06911671 — EMG Control Assistance Virtual Reality Interface Coupled With Cerebellar-iTBS for Arm Recovery After Stroke (ERICA) · NA · recruiting
- NCT07075770 — Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the DMN in Mild AD Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06576999 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S. Fondazione Santa Lucia
- Last refreshed: 29 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06576999.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing